Armando de Oliveira Schubach Selected Research

Armando de Oliveira Schubach Research Topics

12	Cutaneous Leishmaniasis 01/2021 - 05/2005
8	Leishmaniasis 01/2024 - 12/2004
2	Visceral Leishmaniasis (Kala Azar) 07/2008 - 12/2004
1	Hearing Loss (Hearing Impairment) 01/2024
1	Ototoxicity 01/2024
1	Tinnitus 01/2024
1	Sporotrichosis 01/2019
1	Communicable Diseases (Infectious Diseases) 12/2017
1	Varicose Ulcer (Ulcer, Venous) 04/2017
1	Wounds and Injuries (Trauma) 04/2017
1	Ulcer 04/2017
1	Eczema 07/2014
1	Infections 07/2014
1	Hemorrhage 07/2014
1	Pathologic Complete Response 11/2008

14	Meglumine AntimoniateIBA 01/2024 - 05/2005
2	Pentamidine (NebuPent)FDA LinkGeneric 01/2019 - 03/2011
2	DNA (Deoxyribonucleic Acid)IBA 04/2017 - 04/2010
2	Immunoglobulin G (IgG)IBA 01/2009 - 07/2008
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2019
1	Melanins (Melanin)IBA 01/2019
1	Prednisone (Sone)FDA LinkGeneric 04/2017
1	AntimonyIBA 01/2017
1	Histones (Histone)IBA 01/2015
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2015
1	SteroidsIBA 07/2014
1	Kinetoplast DNA (kDNA)IBA 04/2010
1	AntibodiesIBA 01/2009
1	EnzymesIBA 01/2009
1	Itraconazole (Sporanox)FDA LinkGeneric 11/2008
1	AntigensIBA 07/2008
1	IsoenzymesIBA 12/2004

4	Therapeutics 04/2017 - 08/2012
1	Complementary Therapies (Alternative Medicine) 12/2017
1	Intralesional Injections 03/2017
1	Injections 01/2015
1	Aftercare (After-Treatment) 01/2015
1	Contraindications 08/2012
1	Euthanasia (Mercy Killing) 12/2004